Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAP3K11 | Q16584 | 7/20 | 1.00 |
| ▸ | MAP3K9 | P80192 | 6/20 | 1.00 |
| ▸ | PRKCA | P17252 | 4/20 | 1.00 |
| ▸ | PRKCQ | Q04759 | 3/20 | 1.00 |
| ▸ | PRKCD | Q05655 | 3/20 | 1.00 |
| ▸ | GLI1 | P08151 | 2/20 | 1.00 |
| ▸ | GLI2 | P10070 | 2/20 | 1.00 |
| ▸ | PRKD3 | O94806 | 2/20 | 1.00 |
| ▸ | PRKCG | P05129 | 2/20 | 1.00 |
| ▸ | PRKCB | P05771 | 2/20 | 1.00 |
| ▸ | PRKCH | P24723 | 2/20 | 1.00 |
| ▸ | PRKCI | P41743 | 2/20 | 1.00 |
| ▸ | PRKCE | Q02156 | 2/20 | 1.00 |
| ▸ | PRKCZ | Q05513 | 2/20 | 1.00 |
| ▸ | PRKD1 | Q15139 | 2/20 | 1.00 |
| ▸ | CDK4 | P11802 | 1/20 | 1.00 |
| ▸ | CTRB1 | P17538 | 1/20 | 1.00 |
| ▸ | PRKACA | P17612 | 1/20 | 1.00 |
| ▸ | PRKACG | P22612 | 1/20 | 1.00 |
| ▸ | PRKACB | P22694 | 1/20 | 1.00 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Staurosporinone SCHEMBL5440281 | 1.00 | MAP3K11 (1.00) | MAP3K11MAP3K9PRKCAPRKCQPRKCD | |
| Staurosporinone SCHEMBL29374983 | 1.00 | MAP3K11 (1.00) | MAP3K11MAP3K9PRKCAPRKCQPRKCD | |
| SCHEMBL9263371 | 0.88 | MAP3K11 (0.78) | MAP3K11MAP3K9PRKCAPRKCQPRKCD | |
| SCHEMBL9270827 | 0.88 | MAP3K11 (0.78) | MAP3K11MAP3K9PRKCAPRKCQPRKCD | |
| SCHEMBL9260091 | 0.85 | ROCK2 (0.78) | MAP3K11MAP3K9PRKCAPRKCQPRKCD | |
| SCHEMBL9263506 | 0.85 | ROCK2 (0.78) | MAP3K11MAP3K9PRKCAPRKCQPRKCD | |
| SCHEMBL13639843 | 0.83 | MAP3K11 (1.00) | MAP3K11MAP3K9PRKCAPRKCQPRKCD | |
| SCHEMBL13639845 | 0.83 | MAP3K11 (1.00) | MAP3K11MAP3K9PRKCAPRKCQPRKCD | |
| SCHEMBL13140090 | 0.83 | MAP3K11 (1.00) | MAP3K11MAP3K9PRKCAPRKCQPRKCD | |
| SCHEMBL13431719 | 0.82 | MAP3K11 (0.69) | MAP3K11MAP3K9PRKCAPRKCQPRKCD |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 33 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-118166003-A | Genetically engineered bacteria for producing staurosporine and application thereof | 上海医药工业研究院有限公司 | 2024-06-11 | — | — | CN | claimed |
| CN-112980864-B | Recombinant escherichia coli for synthesizing anticancer drug intermediate, and construction method and application thereof | 百缮药业(苏州)有限公司 | 2024-04-26 | — | — | CN | claimed |
| US-20230285556-A1 | METHODS AND COMPOSITIONS FOR TREATING CANCER | OMEROS CORPORATION | 2023-09-14 | — | — | US | claimed |
| CN-113025549-B | Biological glycosyl synthesis system of staurosporine framework compound and synthesis method thereof | 百缮药业(苏州)有限公司 | 2023-06-02 | — | — | CN | claimed |
| WO-2023039578-A1 | METHODS AND COMPOSITIONS FOR TREATING CANCER | OMEROS CORPORATION (US) | 2023-03-16 | — | — | WO | claimed |
| CN-115678937-A | Biosynthesis method and application of K252c derivative | 百缮药业(苏州)有限公司 | 2023-02-03 | — | — | CN | claimed |
| US-20250270746-A1 | STABILIZED FABRICS | OWENS CORNING INTELLECTUAL CAPITAL, LLC | 2025-08-28 | — | — | US | disclosed |
| US-20250263873-A1 | HYBRID FABRIC | OWENS CORNING INTELLECTUAL CAPITAL, LLC | 2025-08-21 | — | — | US | disclosed |
| EP-4519080-A1 | STABILIZED FABRICS | Owens-Corning Intellectual Capital, LLC (US) | 2025-03-12 | — | — | EP | disclosed |
| EP-4519483-A1 | HYBRID FABRIC | Owens-Corning Intellectual Capital, LLC (US) | 2025-03-12 | — | — | EP | disclosed |
| US-12145968-B2 | Recombinant HIV-1 envelope proteins and their use | THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES (US) | 2024-11-19 | — | — | US | disclosed |
| US-20240366627-A1 | SMALL MOLECULES FOR MOUSE SATELLITE CELL PROLIFERATION | PRESIDENT AND FELLOWS OF HARVARD COLLEGE | 2024-11-07 | — | — | US | disclosed |
| CN-118166003-A | Genetically engineered bacteria for producing staurosporine and application thereof | 上海医药工业研究院有限公司 | 2024-06-11 | — | — | CN | disclosed |
| CN-115678937-A | Biosynthesis method and application of K252c derivative | 百缮药业(苏州)有限公司 | 2023-02-03 | — | — | CN | disclosed |
| CN-115678937-A | Biosynthesis method and application of K252c derivative | 百缮药业(苏州)有限公司 | 2023-02-03 | — | — | CN | disclosed |
| CN-115678937-A | Biosynthesis method and application of K252c derivative | 百缮药业(苏州)有限公司 | 2023-02-03 | — | — | CN | disclosed |
| US-11459360-B2 | Recombinant HIV-1 envelope proteins and their use | THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES (US) | 2022-10-04 | — | — | US | disclosed |
| US-20220291237-A1 | Gene Expression Inflammatory Age and Its Uses | Edifice Health, Inc. (US) | 2022-09-15 | — | — | US | disclosed |
| US-11319320-B2 | PIM kinase inhibitor compositions, methods, and uses thereof | SNAP BIO, INC. (US) | 2022-05-03 | — | — | US | disclosed |
| US-20220054499-A1 | SMALL MOLECULES FOR MOUSE SATELLITE CELL PROLIFERATION | PRESIDENT AND FELLOWS OF HARVARD COLLEGE | 2022-02-24 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20220054499-A1 | SMALL MOLECULES FOR MOUSE SATELLITE CELL PROLIFERATION | MKI67, MYLK2, MYH2 | MAP3K11 1431/4885MAP3K9 1685/4885PRKCA 797/4885 |
| US-20230285556-A1 | METHODS AND COMPOSITIONS FOR TREATING CANCER | TP53, CD4, MCL1 | MAP3K11 3749/4885MAP3K9 4080/4885PRKCA 1356/4885 |
| US-20240366627-A1 | SMALL MOLECULES FOR MOUSE SATELLITE CELL PROLIFERATION | MKI67, MYLK2, MYH2 | MAP3K11 1431/4885MAP3K9 1685/4885PRKCA 797/4885 |
| US-11319320-B2 | PIM kinase inhibitor compositions, methods, and uses thereof | PIM1, PIM2, PIM3 | MAP3K11 30/4885MAP3K9 20/4885PRKCA 19/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.